2023
2023.04 Selected as a Korean Fund
for Regenerative Medicine
(PI: Seoul St. Mary's Hospital)
2023.08 Attracting investment of Series-A
2023.10 Identified as a high-tech enterprise
(Ministry of Science and ICT)
2022
2022.03 Selected as an Innovative Startup Package
(BIG3 → DIPS 1000+)
2022.06 Attracting investment of SEED
2022.08 High-tech product Certification
(Ministry of Trade, Industry and Energy) Production equipment Installation and
operation in cGMP facility
(Catholic University's Cell Therapeutics Center) 2022.09 Selected as a R&D linked to Materials, Parts &
Equipment
2021
2021.04 Selected as ‘The GS Challenge’ biotech
company
2021.05 Certification of R&D center
Patent technology transfer(L/I)_POSTECH
2021.07 Selected as a Korean Fund for
Regenerative Medicine
(PI: Gachon University Medical School)
2021.08 Attracting investment of SEED
2021.10 Selected as a Tech Incubaton Program
for Startup (TIPS)
Selected as a ‘100 Startups from Materials,
Parts & Equipment'
2020
2020.04 Selected as a Innovative Pharmaceutical
Company
(Korea Health Industry Development Institute)
2020.05 Selected as a POSCO IMP
2020.08 Establishment of Sphebio Corporation
2020.09 Attracting investment of SEED
